Congratulations to Takuya Tada in our lab for getting the 2023 Outstanding Postdoc Award at NYU Langone Health!

https://www.biorxiv.org/content/10.1101/2021.12.28.474369v1

https://www.biorxiv.org/content/10.1101/2021.10.19.463727v1

https://www.forbes.com/sites/nicholasreimann/2021/07/20/johnson--johnson-vaccine-far-less-effective-against-delta-variant-study-suggests/...

https://twitter.com/i/status/1412559070914093056

https://www.medpagetoday.com/special-reports/exclusives/93458

https://www.youtube.com/watch?v=agaoTSOxDCU

https://news.yahoo.com/pfizer-moderna-vaccines-effective-against-171414504.html

https://www.nytimes.com/2021/04/22/health/covid-ny-variant-vaccine.html

https://www.news-medical.net/news/20210209/Pfizer-BioNTech-COVID-19-vaccine-effective-against-variants-study-shows.aspx

Check out our work on the ACE2 microbody as a potent inhibitor of the SARS-CoV-2 virus published in Cell Reports. Congratulations and...

https://www.nature.com/naturecareers/job/postdoctoral-position-in-hiv-and-sarscov2-immune-response-and-vaccine-development-nyu-langone-me...

Congratulations Takuya!

CARISMA Therapeutics Inc. now shares the license to use the vpx lentiviral vector created in our lab to facilitate the development of...

On Monday, the lab celebrated one of our postdoc researchers, Ramajit Kaur, who was one of four recepients of the prestigious Leon Levy...